
|Videos|May 26, 2023
Private equity: COVID-19 funding and fraud
Author(s)Richard Payerchin, Logan Lutton
Examining where the money went.
Advertisement
The U.S. government poured billions of dollars to help physicians, patients, and businesses endure the COVID-19 pandemic. Now there is more scrutiny over how that money was spent. Jolie Apicella, JD, previously worked as an assistant United States attorney and chief of health care fraud in the Eastern District of New York. Now in private practice, in this video series she explains the current regulatory environment and what doctors and investors should consider when joining private equity with medical enterprises.
Advertisement
Advertisement
Advertisement
Trending on Medical Economics
1
MedPAC to Congress: Here’s how to rework Medicare’s misaligned incentives
2
Medical AI scores high on exams but stumbles on real patient care, new benchmark finds
3
MedPAC: $1.1 trillion in Medicare payments are generating the wrong incentives
4
HHS announces $700M for behavioral health, homelessness; GLP-1s and your skin; opioid clinic, ex-CEO to pay $10.2M in fraud case – Morning Medical Update
5





